Navidea Biopharma (NAVB) Reports In-Line Q4 Loss of 8c/Share

March 6, 2013 4:26 PM

Navidea Biopharmaceuticals (NYSE: NAVB) reported Q4 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found